Navigation Links
AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
Date:9/17/2007

Healthcare Veteran Joins Company's Executive Team

VIRGINIA BEACH, Va., Sept. 17 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) today announced that Mary McCluskey, MD, has been named Chief Medical Officer to oversee healthcare services for the Company's 1.5 million members.

"We are excited to welcome Dr. McCluskey to AMERIGROUP," said James G. Carlson, AMERIGROUP President and Chief Executive Officer. "Throughout her career, she has distinguished herself as an attending clinician, physician executive and leader of a major healthcare organization. She has the experience and the commitment to help AMERIGROUP expand its mission of bringing quality healthcare to the financially vulnerable, seniors and people with disabilities."

"I'm honored to join such an experienced team and to assist AMERIGROUP and the 1.5 million members it serves," McCluskey said. "This is an exciting time for the Company, and I look forward to contributing to its efforts of bringing quality care and service coordination to those who need it most."

For the past eight years, Dr. McCluskey has served in a variety of senior medical positions with Aetna Inc., most recently as Chief Medical Officer, Northeast Region. In this role, she was the senior clinical and medical quality leader for a division that provided health insurance for 2.4 million people through employer-sponsored and Medicare programs. Under her guidance, the company's Northeast region earned an excellent accreditation rating from the National Committee for Quality Assurance. Her previous positions at Aetna included National Medical Director/Head of Clinical Cost Management and Senior Regional Medical Director, Southeast Region.

Prior to Aetna, McCluskey was Vice President of Medical Affairs for Medpartners Medical Management in Tampa. She previously served as Internist/Medical Director of Bridgeton Health Center in St. Louis. McCluskey began her career as an Urgent Care Physician in St. Louis. A graduate of St. Louis University and the St. Louis University School of Medicine, she completed her residency in Internal Medicine at Jewish Hospital/Washington University in St. Louis.

AMERIGROUP offers disease management programs for 11 different conditions, ranging from asthma and diabetes to AIDS and schizophrenia, eight of which are accredited by the National Committee for Quality Assurance. The Company's health plan in the District of Columbia has also obtained accreditation and a rating of commendable from the NCQA. All AMERIGROUP health plans in the District and nine states offer members a range of initiatives that are designed to connect the 1.5 million members with quality, preventive healthcare programs that target the specific needs of low-income Americans.

About AMERIGROUP Corporation

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.5 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com .

CONTACTS:

Investors: Julie Loftus Trudell News Media: Kent Jenkins, Jr.

AMERIGROUP Corporation AMERIGROUP Corporation

Senior Vice President, Senior Vice President,

Investor Relations Communications

(757) 321-3597 (757) 518-3671


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
11. EU medical chief says Europe ready for bird flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... , ... The Waismann Method® is providing a faster, safer, and ... victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... the shame, stigma, and harmful labeling believed to prevent many of these ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important webinar— ... 23, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , If you want to find out what really happened in the seniors ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... the quarter and full fiscal year ended December 31, 2016. ... ... Company,s audited financial statements and management discussion and analysis for ... been filed on SEDAR and are available at www.sedar.com ...
(Date:2/22/2017)... Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Fourth Quarter 2016 investor conference call and webcast at ... The call will cover an update on Merrimack,s recent ... full year 2016 financial results. A press release detailing the ... the morning of Wednesday, March 1. Investors and the general ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology: